COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222

Clinical trial NCT04864561 · COMPLETED

Trial details

NCT number: NCT04864561
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Virus Infection

Start date: 2021-04-26
Primary completion: 2021-07-19
Enrollment: 4034

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.